Comparative gene expression profiles of intestinal transporters in mice, rats and humans

Pharmacological Research

Volumn 56, Issue 3, 2007, Pages 224-236

  Kim, Hye Ryoung ^a   Park, Sung Won ^a   Cho, Hee Jung ^a   Chae, Kyung Ae ^a   Sung, Ji Min ^a   Kim, Jin Suk ^a   Landowski, Christopher P ^b   Sun, Duxin ^b   Abd El Aty, A M ^a,c   Amidon, Gordon L ^b   Shin, Ho Chul ^a  

^a Konkuk University   (South Korea)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Cairo University   (Egypt)

Author keywords

Animals; Gene expression; Humans; Intestine; Transporters

Indexed keywords

4F2HC; AMINO ACID TRANSPORTER; ASC1; CNT2; CSNU1; CSNU3; CT1; FABP1; FABP2; FATTY ACID TRANSPORTER; FOLATE BINDING PROTEIN; FOLT; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 5; HPT1; LAT3; MESSENGER RNA; NBC3; NUCLEOSIDE TRANSPORTER; OCT5; ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER; PEPTIDE TRANSPORTER 1; PROT; RNA; SDCT1; SFXN1; SGLT1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DRUG TRANSPORT; ENZYME SPECIFICITY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; INTESTINE ABSORPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACID TRANSPORT SYSTEMS; ANIMALS; CARRIER PROTEINS; DUODENUM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NUCLEOSIDE TRANSPORT PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; P-GLYCOPROTEINS; PEPTIDES; RATS; RNA, MESSENGER;

EID: 34548203927     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.06.005     Document Type: Article

References (108)

1. Fang H., Tong W., Perkins R., Shi L., Hong H., Cao X., et al. Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling. BMC Bioinform 6 Suppl 2 (2005) S6
2. Ganter B., Tugendreich S., Pearson C.I., Ayanoglu E., Baumhueter S., Bostian K.A., et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 119 (2005) 219-244
3. Nees M., and Woodworth C.D. Microarrays: spotlight on gene function and pharmacogenomics. Curr Cancer Drug Targets 1 (2001) 155-175
4. Landowski C.P., Sun D., Foster D.R., Menon S.S., Barnett J.L., Welage L.S., et al. Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters. J Pharmacol Exp Ther 306 (2003) 778-786
5. Takara K., Ohnishi N., Horibe S., and Yokoyama T. Expression profiles of drug-metabolizing enzyme CYP3A and drug efflux transporter multidrug resistance 1 subfamily mRNAS in small intestine. Drug Metab Dispos 31 (2003) 1235-1239
6. Cao X., Gibbs S.T., Fang L., Miller H.A., Landowski C.P., Shin H.C., et al. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res (2006)
7. Alper J. Drug delivery. Breaching the membrane. Science 296 (2002) 838-839
8. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
9. Sun D., Lennernas H., Welage L.S., Barnett J.L., Landowski C.P., Foster D., et al. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res 19 (2002) 1400-1416
10. Shin H.C., Landowski C.P., Sun D., and Amidon G.L. Transporters in the GI tract. In: Waterbeemd H.V.-d., Lennernas H., and Artursson P. (Eds). Drug bioavailability/estimation of solubility, permeability and absorption: Vol. 18, methods and principles in medicinal chemistry (2003), Wiley-VCH, Weinheim 245-287
11. Tsuji A., and Tamai I. Carrier-mediated intestinal transport of drugs. Pharm Res 13 (1996) 963-977
12. Yan Q., and Sadee W. Human membrane transporter database: a Web-accessible relational database for drug transport studies and pharmacogenomics. AAPS PharmSci 2 (2000) E20
13. Norinder U. In silico modelling of ADMET-a minireview of work from 2000 to 2004. SAR QSAR Environ Res 16 (2005) 1-11
14. van de Waterbeemd H., and Gifford E. ADMET in silico modelling: towards prediction paradise?. Nat Rev Drug Discov 2 (2003) 192-204
15. Clark D.E., and Grootenhuis P.D. Progress in computational methods for the prediction of ADMET properties. Curr Opin Drug Discov Dev 5 (2002) 382-390
16. Fiegler H., and Carter N.P. Genomic array technology. Methods Cell Biol 75 (2004) 769-785
17. Anderle P., Huang Y., and Sadee W. Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. Eur J Pharm Sci 21 (2004) 17-24
18. Yang C.Y., Dantzig A.H., and Pidgeon C. Intestinal peptide transport systems and oral drug availability. Pharm Res 16 (1999) 1331-1343
19. Lee V.H., Chu C., Mahlin E.D., Basu S.K., Ann D.K., Bolger M.B., et al. Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1. J Control Release 62 (1999) 129-140
20. Lipka E., Crison J., and Amidon G.L. Transmembrane transport of peptide type compounds: prospects for oral delivery. J Control Release 39 (1996) 121-129
21. Adibi S.A. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 113 (1997) 332-340
22. Rubio-Aliaga I., and Daniel H. Mammalian peptide transporters as targets for drug delivery. Trends Pharmacol Sci 23 (2002) 434-440
23. Daniel H. Function and molecular structure of brush border membrane peptide/H+ symporters. J Membr Biol 154 (1996) 197-203
24. Detmers F.J., Lanfermeijer F.C., and Poolman B. Peptides and ATP binding cassette peptide transporters. Res Microbiol 152 (2001) 245-258
25. Inui K., Terada T., Masuda S., and Saito H. Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2. Nephrol Dial Transplant 15 Suppl 6 (2000) 11-13
26. Meredith D., and Boyd C.A. Structure and function of eukaryotic peptide transporters. Cell Mol Life Sci 57 (2000) 754-778
27. Ganapathy V., and Leibach F.H. Peptide transporters. Curr Opin Nephrol Hypertens 5 (1996) 395-400
28. Leibach F.H., and Ganapathy V. Peptide transporters in the intestine and the kidney. Annu Rev Nutr 16 (1996) 99-119
29. Wenzel U., Thwaites D.T., and Daniel H. Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter. Br J Pharmacol 116 (1995) 3021-3027
30. Oxender D.L. Membrane transport. Annu Rev Biochem 41 (1972) 777-814
31. Palacin M., Estevez R., Bertran J., and Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 78 (1998) 969-1054
32. Takada Y., Greig N.H., Vistica D.T., Rapoport S.I., and Smith Q.R. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier. Cancer Chemother Pharmacol 29 (1991) 89-94
33. Yanagida O., Kanai Y., Chairoungdua A., Kim D.K., Segawa H., Nii T., et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta 1514 (2001) 291-302
34. Kim D., Kanai Y., Choi H., Tangtrongsup S., Chairoungdua A., Babu E., et al. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta 1565 (2002) 112
35. Amidon G.L., Merfeld A.E., and Dressman J.B. Concentration and pH dependency of alpha-methyldopa absorption in rat intestine. J Pharm Pharmacol 38 (1986) 363-368
36. Hu M., and Borchardt R.T. Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm Res 7 (1990) 1313-1319
37. Cercos-Fortea T., Polache A., Nacher A., Cejudo-Ferragud E., Casabo V.G., and Merino M. Influence of leucine on intestinal baclofen absorption as a model compound of neutral alpha-aminoacids. Biopharm Drug Dispos 16 (1995) 563-577
38. Shindo H., Komai T., and Kawai K. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). V. Mechanism of intestinal absorption of D- and L-DOPA-14C in rats. Chem Pharm Bull (Tokyo) 21 (1973) 2031-2038
39. Uchino H., Kanai Y., Kim do K., Wempe M.F., Chairoungdua A., Morimoto E., et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol 61 (2002) 729-737
40. Fraga S., Serrao M.P., and Soares-da-Silva P. The L-3,4-dihydroxyphenylalanine transporter in human and rat epithelial intestinal cells is a type 2 hetero amino acid exchanger. Eur J Pharmacol 441 (2002) 127-135
41. +-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem 276 (2001) 17221-17228
42. Thwaites D.T., Armstrong G., Hirst B.H., and Simmons N.L. D-cycloserine transport in human intestinal epithelial (Caco-2) cells: mediation by a H(+)-coupled amino acid transporter. Br J Pharmacol 115 (1995) 761-766
43. Simmons-Willis T.A., Koh A.S., Clarkson T.W., and Ballatori N. Transport of a neurotoxicant by molecular mimicry: the methylmercury-l-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem J 367 (2002) 239-246
44. Wang J., Schaner M.E., Thomassen S., Su S.F., Piquette-Miller M., and Giacomini K.M. Functional and molecular characteristics of Na(+)-dependent nucleoside transporters. Pharm Res 14 (1997) 1524-1532
45. +-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). Mol Membr Biol 18 (2001) 65-72
46. Hyde R.J., Cass C.E., Young J.D., and Baldwin S.A. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18 (2001) 53-63
47. Pastor-Anglada M., Casado F.J., Valdes R., Mata J., Garcia-Manteiga J., and Molina M. Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol 18 (2001) 81-85
48. Balimane P.V., and Sinko P.J. Involvement of multiple transporters in the oral absorption of nucleoside analogues. Adv Drug Deliv Rev 39 (1999) 183-209
49. Xiao G., Wang J., Tangen T., and Giacomini K.M. A novel proton-dependent nucleoside transporter, CeCNT3, from Caenorhabditis elegans. Mol Pharmacol 59 (2001) 339-348
50. Gorboulev V., Ulzheimer J.C., Akhoundova A., Ulzheimer-Teuber I., Karbach U., Quester S., et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16 (1997) 871-881
51. Busch A.E., Quester S., Ulzheimer J.C., Waldegger S., Gorboulev V., Arndt P., et al. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. J Biol Chem 271 (1996) 32599-32604
52. Busch A.E., Quester S., Ulzheimer J.C., Gorboulev V., Akhoundova A., Waldegger S., et al. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395 (1996) 153-156
53. Kekuda R., Prasad P.D., Wu X., Wang H., Fei Y.J., Leibach F.H., et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273 (1998) 15971-15979
54. Wu X., Kekuda R., Huang W., Fei Y.J., Leibach F.H., Chen J., et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273 (1998) 32776-32786
55. Yabuuchi H., Tamai I., Nezu J., Sakamoto K., Oku A., Shimane M., et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289 (1999) 768-773
56. Wu X., George R.L., Huang W., Wang H., Conway S.J., Leibach F.H., et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 1466 (2000) 315-327
57. Wang Y., Taroni F., Garavaglia B., and Longo N. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation. Hum Mutat 16 (2000) 401-407
58. Ohashi R., Tamai I., Yabuuchi H., Nezu J.I., Oku A., Sai Y., et al. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291 (1999) 778-784
59. Wagner C.A., Lukewille U., Kaltenbach S., Moschen I., Broer A., Risler T., et al. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol 279 (2000) F584-F591
60. Sekine T., Cha S.H., and Endou H. The multispecific organic anion transporter (OAT) family. Pflugers Arch 440 (2000) 337-350
61. Sekine T., Cha S.H., Tsuda M., Apiwattanakul N., Nakajima N., Kanai Y., et al. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429 (1998) 179-182
62. Simonson G.D., Vincent A.C., Roberg K.J., Huang Y., and Iwanij V. Molecular cloning and characterization of a novel liver-specific transport protein. J Cell Sci 107 Pt 4 (1994) 1065-1072
63. Kusuhara H., Sekine T., Utsunomiya-Tate N., Tsuda M., Kojima R., Cha S.H., et al. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274 (1999) 13675-13680
64. Kusuhara H., and Sugiyama Y. Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release 78 (2002) 43-54
65. Meier P.J., Eckhardt U., Schroeder A., Hagenbuch B., and Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 26 (1997) 1667-1677
66. Muller M., and Jansen P.L. Molecular aspects of hepatobiliary transport. Am J Physiol 272 (1997) G1285-G1303
67. Abu-Zahra T.N., Wolkoff A.W., Kim R.B., and Pang K.S. Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes. Drug Metab Dispos 28 (2000) 801-806
68. Ishizuka H., Konno K., Naganuma H., Nishimura K., Kouzuki H., Suzuki H., et al. Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide. J Pharmacol Exp Ther 287 (1998) 37-42
69. Reichel C., Gao B., Van Montfoort J., Cattori V., Rahner C., Hagenbuch B., et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology 117 (1999) 688-695
70. Isern J., Hagenbuch B., Stieger B., Meier P.J., and Meseguer A. Functional analysis and androgen-regulated expression of mouse organic anion transporting polypeptide 1 (Oatp1) in the kidney. Biochim Biophys Acta 1518 (2001) 73-78
71. Hagenbuch B., Adler I.D., and Schmid T.E. Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X. Biochem J 345 Pt 1 (2000) 115-120
72. Eckhardt U., Schroeder A., Stieger B., Hochli M., Landmann L., Tynes R., et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. Am J Physiol 276 (1999) G1037-G1042
73. Tamai I., Takanaga H., Maeda H., Sai Y., Ogihara T., Higashida H., et al. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem Biophys Res Commun 214 (1995) 482-489
74. Garcia C.K., Goldstein J.L., Pathak R.K., Anderson R.G., and Brown M.S. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 76 (1994) 865-873
75. Ackley D.C., and Yokel R.A. Aluminum citrate is transported from brain into blood via the monocarboxylic acid transporter located at the blood-brain barrier. Toxicology 120 (1997) 89-97
76. Joost H.G., and Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18 (2001) 247-256
77. +/glucose cotransporter SGLT2 reveal a common mechanism for SGLT1 and SGLT2. J Biol Chem 271 (1996) 32678-32683
78. +/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for d-glucose. J Clin Invest 93 (1994) 397-404
79. Burant C.F., Takeda J., Brot-Laroche E., Bell G.I., and Davidson N.O. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 267 (1992) 14523-14526
80. Olson A.L., and Pessin J.E. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 16 (1996) 235-256
81. Wright E.M. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol 280 (2001) F10-F18
82. Mizuma T., Ohta K., Hayashi M., and Awazu S. Intestinal active absorption of sugar-conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs. Biochem Pharmacol 43 (1992) 2037-2039
83. Mizuma T., Ohta K., and Awazu S. The beta-anomeric and glucose preferences of glucose transport carrier for intestinal active absorption of monosaccharide conjugates. Biochim Biophys Acta 1200 (1994) 117-122
84. Geourjon C., Orelle C., Steinfels E., Blanchet C., Deleage G., Di Pietro A., et al. A common mechanism for ATP hydrolysis in ABC transporter and helicase superfamilies. Trends Biochem Sci 26 (2001) 539-544
85. Dean M., Rzhetsky A., and Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11 (2001) 1156-1166
86. Borst P., and Elferink R.O. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71 (2002) 537-592
87. Dassa E., and Schneider E. The rise of a protein family: ATP-binding cassette systems. Res Microbiol 152 (2001) 203
88. Dean M., and Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 6 (2005) 123-142
89. Jones P.M., and George A.M. The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci 61 (2004) 682-699
90. Dean M., Hamon Y., and Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42 (2001) 1007-1017
91. Abumrad N., Harmon C., and Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 39 (1998) 2309-2318
92. Abumrad N., Coburn C., and Ibrahimi A. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1441 (1999) 4-13
93. Hamilton J.A., and Kamp F. How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids?. Diabetes 48 (1999) 2255-2269
94. Schaffer J.E., and Lodish H.F. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79 (1994) 427-436
95. Hirsch D., Stahl A., and Lodish H.F. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci USA 95 (1998) 8625-8629
96. Stahl A., Hirsch D.J., Gimeno R.E., Punreddy S., Ge P., Watson N., et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 4 (1999) 299-308
97. Herrmann T., Buchkremer F., Gosch I., Hall A.M., Bernlohr D.A., and Stremmel W. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene 270 (2001) 31-40
98. Liang W.J., Johnson D., and Jarvis S.M. Vitamin C transport systems of mammalian cells. Mol Membr Biol 18 (2001) 87-95
99. +-dependent l-ascorbic acid transporters. Nature 399 (1999) 70-75
100. Wang H., Dutta B., Huang W., Devoe L.D., Leibach F.H., Ganapathy V., et al. Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim Biophys Acta 1461 (1999) 1-9
101. Eudy J.D., Spiegelstein O., Barber R.C., Wlodarczyk B.J., Talbot J., and Finnell R.H. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol Genet Metab 71 (2000) 581-590
102. Rajgopal A., Edmondnson A., Goldman I.D., and Zhao R. SLC19A3 encodes a second thiamine transporter ThTr2. Biochim Biophys Acta 1537 (2001) 175-178
103. Prasad P.D., Wang H., Kekuda R., Fujita T., Fei Y.J., Devoe L.D., et al. Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J Biol Chem 273 (1998) 7501-7506
104. +-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization. J Biol Chem 274 (1999) 14875-14883
105. Takanaga H., Maeda H., Yabuuchi H., Tamai I., Higashida H., and Tsuji A. Nicotinic acid transport mediated by pH-dependent anion antiporter and proton cotransporter in rabbit intestinal brush-border membrane. J Pharm Pharmacol 48 (1996) 1073-1077
106. Cox B., Kislinger T., and Emili A. Integrating gene and protein expression data: pattern analysis and profile mining. Methods 35 (2005) 303-314
107. Greenbaum D., Jansen R., and Gerstein M. Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts. Bioinformatics 18 (2002) 585-596
108. Terada T., and Inui K. Gene expression and regulation of drug transporters in the intestine and kidney. Biochem Pharmacol 73 (2007) 440-449